NEW YORK (
) hit a new 52-week low Friday as it is currently trading at $11.81, below its previous 52-week high of $18.87 with 212,752 shares traded as of 2:01 p.m. ET. Average volume has been 274,200 shares over the past 30 days.
PetMed Express has a market cap of $259 million and is part of the
industry. Shares are down 33.1% year to date as of the close of trading on Thursday.
PetMed Express, Inc., doing business as 1-800-PetMeds, markets non-prescription and prescription pet medications; and other health products for dogs, cats, and horses. The company has a P/E ratio of 13, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
- Practice your PETS trading strategies and win cash in our stock game.
TheStreet Ratings rates PetMed Express as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. However, as a counter to these strengths, we also find weaknesses including feeble growth in the company's earnings per share, deteriorating net income and weak operating cash flow. You can view the full
or get investment ideas from our